12:00 AM
Jul 13, 2009
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

Genomas preclinical data

Genomas Inc., Hartford, Conn.
Product: SINM PhyzioType System
Indication: Predict risk of statin-induced neuromyopathy
Based on blood samples from 442 subjects on statin treatment, the company characterized 384...

Read the full 129 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >